Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.34% |
| 2 | Financials | 5.75% |
| 3 | Healthcare | 5.71% |
| 4 | Consumer Discretionary | 5.08% |
| 5 | Industrials | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3801
CALL
Chemours
CC
$2.37B
| $797K | ﹤0.01% |
20,200
+400
| +2% | +$17.5K |
|
3802
Huron Consulting
HURN
$2.42B
| $797K | ﹤0.01% |
16,117
-5,670
| -26% | -$265K |
|
|
SFIX
3803
PUT
Stitch Fix
SFIX
$478M
| $797K | ﹤0.01% |
18,200
+8,400
| +86% | +$306K |
|
|
FOE
3804
DELISTED
Ferro Corporation
FOE
| $796K | ﹤0.01% |
34,280
+26,306
| +330% | +$582K |
|
|
USCR
3805
DELISTED
U S Concrete, Inc.
USCR
| $796K | ﹤0.01% |
17,331
+5,590
| +48% | +$281K |
|
3806
Mueller Water Products
MWA
$3.98B
| $795K | ﹤0.01% |
69,084
+57,654
| +504% | +$682K |
|
3807
PUT
Hartford Financial Services
HIG
$38B
| $794K | ﹤0.01% |
15,900
-3,700
| -19% | -$190K |
|
|
NE
3808
PUT
DELISTED
Noble Corporation
NE
| $794K | ﹤0.01% |
113,000
+23,800
| +27% | +$144K |
|
3809
Cannae Holdings
CNNE
$647M
| $790K | ﹤0.01% |
37,660
-27,924
| -43% | -$546K |
|
3810
CALL
Golar LNG
GLNG
$5.34B
| $790K | ﹤0.01% |
28,400
-30,700
| -52% | -$813K |
|
3811
Covenant Logistics
CVLG
$887M
| $789K | ﹤0.01% |
54,276
-1,334
| -2% | -$20.2K |
|
3812
PUT
Hain Celestial
HAIN
$53.2M
| $789K | ﹤0.01% |
29,100
-122,400
| -81% | -$3.49M |
|
3813
PUT
Canadian Imperial Bank of Commerce
CM
$113B
| $788K | ﹤0.01% |
16,800
-6,200
| -27% | -$285K |
|
|
BOLD
3814
DELISTED
Audentes Therapeutics, Inc
BOLD
| $788K | ﹤0.01% |
19,896
+15,039
| +310% | +$561K |
|
3815
CALL
Polaris
PII
$3.91B
| $787K | ﹤0.01% |
7,800
-200
| -3% | -$22.3K |
|
3816
AtriCure
ATRC
$2.24B
| $786K | ﹤0.01% |
22,444
+9,204
| +70% | +$291K |
|
3817
CALL
Invesco CurrencyShares British Pound Sterling Trust
FXB
$65M
| $784K | ﹤0.01% |
6,200
+900
| +17% | +$114K |
|
3818
PUT
Watsco Inc
WSO
$12.9B
| $784K | ﹤0.01% |
4,400
-1,000
| -19% | -$177K |
|
|
INST
3819
DELISTED
Instructure, Inc.
INST
| $784K | ﹤0.01% |
22,152
+8,034
| +57% | +$330K |
|
|
OCLR
3820
CALL
DELISTED
Oclaro Inc.
OCLR
| $784K | ﹤0.01% |
87,700
-7,200
| -8% | -$65.2K |
|
|
ESND
3821
DELISTED
Essendant Inc.
ESND
| $780K | ﹤0.01% |
60,821
+47,072
| +342% | +$673K |
|
|
CISN
3822
DELISTED
Cision Ltd. Ordinary Share
CISN
| $779K | ﹤0.01% |
46,361
+36,712
| +380% | +$604K |
|
3823
DigitalBridge
DBRG
$2.94B
| $778K | ﹤0.01% |
31,963
-50,105
| -61% | -$1.23M |
|
3824
Fidelity MSCI Financials Index ETF
FNCL
$2.43B
| $778K | ﹤0.01% |
19,300
+6,000
| +45% | +$246K |
|
3825
CALL
Royal Gold
RGLD
$19.5B
| $778K | ﹤0.01% |
10,100
-8,800
| -47% | -$724K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, up from 7.5% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.